Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • syenfrout syenfrout Dec 8, 2011 7:28 PM Flag

    Don't believe me?

    Glad they couldn't fool you.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Nor could they fool Time either (published two hours ago).

      http://healthland.time.com/2011/12/08/two-drugs-offer-new-hope-for-breast-cancer-patients/

      Pertuzumab and Afinitor are stealing all of the attention. The media doesn't care about Ganatespib's below expectation results.

      Or will lfrhome accuse me of being misleading here as well?

      • 2 Replies to hailstorm_catapult
      • hail, we have had a lot of prolific and giving discussions before. I know by experience that it is hard to buy in after this run, but on the other hand when I previously have been looking on a stock, it hardly stop its run this early. Thake a citrus, bling your eyes and buy somel. This is the beginning, and a small one yet. When folks around the world hear of our drug we will be much much higher.
        Then to the asian partner deal, I dont think a small player is interesting enough for Synta at this stage. It will be sold at some stage but to a major player like Roche, Astra Zeneca of the likes. Our drug is BY FAR the most promising out there period. I have challenged the bio community to find a drug that is more convincing, and no replies have popped up. So again we have the highest flying bird out there, a bird that may dump something on the lesser approved drug plays out there, and then dump a lot ! If for no other reson than obstruction of progress SNTA is already worth a couple of billions ! Yes you heard right, billions !
        Thisis a MAJOR discovery !

 
SNTA
0.343+0.072(+26.61%)Jul 22 4:00 PMEDT